The CEO of pharmaceutical giant AstraZeneca warns that NHS patients may be limited to generic medicines unless the health service increases what it pays for branded drugs, raising concerns about access to cutting-edge treatments.
Exclusive: Health Secretary gains controversial new powers to fast-track medicines, raising concerns about inconsistent care across different regions of England.
Exclusive investigation reveals dangerous counterfeit weight loss medications are being illegally sold across Britain, putting thousands at risk of serious health complications.
Former President Donald Trump's proposed tariffs could dramatically increase costs for NHS medicines, potentially costing the health service billions and threatening patient care across the UK.
The NHS is rolling out three groundbreaking COVID-19 treatments to protect the most vulnerable, including molnupiravir and ritonavir, offering new hope for high-risk patients across the UK.
A groundbreaking HIV prevention injection offering six months of protection with lenacapavir will be available in 120 lower-income countries by 2027 through a landmark access agreement.
Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
The World Health Organisation makes a landmark decision, adding weight-loss injections like Wegovy to its Essential Medicines List, signalling a new front in the global fight against obesity.
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
The European Medicines Agency has approved a groundbreaking HIV prevention drug, marking a significant step forward in public health. Learn more about this medical milestone.